- Chiariho malformace bez myelodysplásie. Zkušenosti s léčbou 50 nemocných2004 | Fakulta tělesné výchovy a sportu
- Chiariho malformace bez myelodysplásie. Zkušenosti s léčbou 50 nemocných2004 | 1. lékařská fakulta
- Chirurgické řešení 50 nemocných s Chiariho malformací bez myelodyspláziePublikace bez příslušnosti k fakultě
- Léčba relapsu myelomu se sekundární myelodysplázií - kazuistika2013 | 1. lékařská fakulta
- Chiari Malformation without Myelodysplasia. Surgical Treatment of 50 CasesPublikace bez příslušnosti k fakultě
- Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms2016 | Publikace bez příslušnosti k fakultě
- Combined immunosupressive treatment in patients with early myelodysplasiaPublikace bez příslušnosti k fakultě
- TRAIL/Apo2L/ supresses growth of primary human leukemia and myelodysplasia progenitors2002 | 1. lékařská fakulta
- TRAIL/Apo2L/ supresses growth of primary human leukemia and myelodysplasia progenitors2002 | Fakulta tělesné výchovy a sportu
- TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD34+ cell repopulation in NOD/SCID micePublikace bez příslušnosti k fakultě
- Chiariho malformacion without myelodysplasia. Surgical treatment of 40 cases. Syringo/- hydromyeliePublikace bez příslušnosti k fakultě
- Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes2018 | Publikace bez příslušnosti k fakultě
- Simultaneous Cerebral and Spinal Fluid Pressure Recordings in Surgical Indications of the Chiari Malformation without Myelodysplasia2001 | 1. lékařská fakulta
- A limited impact of chemotherapy on prolonged survival in myelodysplasia (MDS) : an analysis of 142 patients with advanced diseasePublikace bez příslušnosti k fakultě
- Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes2022 | Ústřední knihovna
- Léčba anemií - 2. část2007 | 1. lékařská fakulta
- A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes2013 | Publikace bez příslušnosti k fakultě
- Transplant results in adults with Fanconi anaemia2018 | 2. lékařská fakulta
- The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia2005 | 1. lékařská fakulta
- The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia2005 | Fakulta tělesné výchovy a sportu
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | 1. lékařská fakulta
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | Publikace bez příslušnosti k fakultě
- Recurrent skin eruption in patient with chronic lymphocytic leukemia and lymphocytic infiltrates of the dermis resembling Sweet's syndrome2011 | 2. lékařská fakulta
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study2014 | Publikace bez příslušnosti k fakultě
- MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia2018 | Publikace bez příslušnosti k fakultě
- The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study2021 | 2. lékařská fakulta
- Experiences on MDS and JMML from the EWOG-MDS2003 | 2. lékařská fakulta
- Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients2021 | 1. lékařská fakulta
- Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment2015 | Lékařská fakulta v Plzni
- Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome2016 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta, Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové